These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29580973)

  • 1. A pre-clinical safety study of PEGylated recombinant human endostatin (M
    Geng X; Guo L; Liu L; Wang C; Peng Q; Qi W; Sun L; Liu X; Miao Y; Lin Z; Fu Y; Luo Y; Li B
    Regul Toxicol Pharmacol; 2018 Jun; 95():190-197. PubMed ID: 29580973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys.
    Guo L; Geng X; Chen Y; Qi F; Liu L; Miao Y; Lin Z; Yu M; Li Z; Fu Y; Li B; Luo Y
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):512-23. PubMed ID: 24878240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of PEGylated recombinant human endostatin in rhesus monkeys.
    Guo L; Li Z; Xu B; Yu M; Fu Y; Liu L; Wang J; Luo Y
    Life Sci; 2019 Dec; 238():116967. PubMed ID: 31626794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of PEGylated recombinant human endostatin (M2ES) in rats.
    Li ZG; Jia L; Guo LF; Yu M; Sun X; Nie W; Fu Y; Rao CM; Wang JZ; Luo YZ
    Acta Pharmacol Sin; 2015 Jul; 36(7):847-54. PubMed ID: 26027657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog.
    Wang S; Fu Y; Luo Y
    Chin J Cancer; 2016 Jan; 35():14. PubMed ID: 26792627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical Efficacy and Safety Pharmacology of PEGylated Recombinant Human Endostatin.
    Guo L; Hua L; Hu B; Wang J
    Curr Mol Med; 2024; 24(3):389-396. PubMed ID: 36999708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality, bioactivity study, and preclinical acute toxicity, safety pharmacology evaluation of PEGylated recombinant human endostatin (M
    Guo L; Geng X; Liu L; Miao Y; Lin Z; Yu M; Fu Y; Liu L; Li B; Luo Y
    J Biochem Mol Toxicol; 2019 Mar; 33(3):e22257. PubMed ID: 30536793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subchronic safety evaluation of EPO-018B, a pegylated peptidic erythropoiesis stimulating agent, after 5-week subcutaneous injection in Cynomolgus monkeys and Sprague-Dawley rats.
    Gong XL; Zhang XD; Li J; Zhang XF; Zong Y; Lu GC; Yuan BJ
    Food Chem Toxicol; 2013 Oct; 60():252-62. PubMed ID: 23911802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of M
    Chen Y; DU Y; Li P; Wu F; Fu Y; Li Z; Luo Y
    Mol Clin Oncol; 2014 Jul; 2(4):586-590. PubMed ID: 24940500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subchronic Oral Toxicity of Sodium Tungstate in Sprague-Dawley Rats.
    McCain WC; Crouse LC; Bazar MA; Roszell LE; Leach GJ; Middleton JR; Reddy G
    Int J Toxicol; 2015; 34(4):336-45. PubMed ID: 26023051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and 13 weeks subchronic toxicological evaluation of naringin in Sprague-Dawley rats.
    Li P; Wang S; Guan X; Liu B; Wang Y; Xu K; Peng W; Su W; Zhang K
    Food Chem Toxicol; 2013 Oct; 60():1-9. PubMed ID: 23871784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical and biological characterization of PEGylated recombinant human endostatin.
    Guo L; Xu B; Zhou D; Chang G; Fu Y; Liu L; Luo Y
    Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):920-927. PubMed ID: 31278773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys.
    Yu KM; Lau JY; Fok M; Yeung YK; Fok SP; Zhang S; Ye P; Zhang K; Li X; Li J; Xu Q; Wong WT; Choo QL
    Toxicol Appl Pharmacol; 2018 Mar; 342():39-49. PubMed ID: 29407773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and repeated dose (28 days) toxicity studies in rats and dogs of recombinant batroxobin, a snake venom thrombin-like enzyme expressed from Pichia pastoris.
    Kim OH; Cho KS; Seomun Y; Kim JT; Chung KH
    Toxicon; 2017 Apr; 129():153-163. PubMed ID: 28161122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonclinical Safety Assessment of a Long-Acting Recombinant PEGylated Factor Eight (BAY 94-9027) With a 60 kDa PEG.
    Ivens IA; Banczyk D; Gutberlet K; Jackman S; Vauléon S; Frisk AL
    Toxicol Pathol; 2019 Jul; 47(5):585-597. PubMed ID: 31132933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and subchronic oral toxicity of Coriolus versicolor standardized water extract in Sprague-Dawley rats.
    Hor SY; Ahmad M; Farsi E; Lim CP; Asmawi MZ; Yam MF
    J Ethnopharmacol; 2011 Oct; 137(3):1067-76. PubMed ID: 21767625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety assessment of Cissus quadrangularis extract (CQR-300): subchronic toxicity and mutagenicity studies.
    Kothari SC; Shivarudraiah P; Venkataramaiah SB; Koppolu KP; Gavara S; Jairam R; Krishna S; Chandrappa RK; Soni MG
    Food Chem Toxicol; 2011 Dec; 49(12):3343-57. PubMed ID: 21983486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity studies of Cupric Sulfate (CAS No. 7758-99-8) Administered in Drinking Water and Feed to F344/N Rats and B6C3F1 Mice.
    Hebert C
    Toxic Rep Ser; 1993 Jul; 29():1-D3. PubMed ID: 12209195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety assessment of Apoaequorin, a protein preparation: subchronic toxicity study in rats.
    Moran DL; Marone PA; Bauter MR; Soni MG
    Food Chem Toxicol; 2013 Jul; 57():1-10. PubMed ID: 23470325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.